香港中旅(00308.HK)控股股東對公司控股架構變動
香港中旅(00308.HK)公布,於上周五(19日)獲控股股東中旅(集團)通知,港中旅資產管理同意收購香港新旅四成股權,於收購前香港新旅持有公司20.52%已發行股本,而中旅(集團)透過港中旅資產持有香港新旅六成股權,據證券及期貨條例中旅(集團)被視為持有香港新旅所持有之公司約20.52%已發行股本,中旅(集團)合共持有公司約61.15%已發行股本。
緊隨收購後,香港新旅將持有公司20.52%的已發行股本,中旅(集團)將繼續持有公司約61.15%的已發行股本,而國新國際投資及Ryden不再持有公司任何已發行股份權益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.